Masahiro Hirakawa, MD, PhD^1*, Tiago R Matos, MD, MSc^1*, John Koreth, MBBS, DPhil¹, Edouard Forcade, MD^1*, Jennifer Whangbo, MD, PhD², Kazuyuki Murase, MD, PhD^1,3, Hongye Liu^1*, Sarah Nikiforow, MD, PhD¹, Vincent T Ho, MD⁴, Corey S Cutler, MD, MPH¹, Philippe Armand, MD, PhD¹, Edwin P. Alyea, MD¹, Joseph H. Antin, MD¹, Robert J. Soiffer, MD⁵ and Jerome Ritz, MD²

¹Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Ryan H Moy, MD, PhD^1,2*, Austin P Huffman, BA^2,3*, Lee P Richman, BA^2*, Lisa Crisalli, BS^2*, James A Hoxie, MD^2*, Robert H Vonderheide, MD, DPhil^2*, David L Porter, MD² and Ran Reshef, MD^3,4

¹Department of Medicine, NewYork-Presbyterian Hospital-Weill Cornell Medical College, New York, NY
²Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
³Division of Hematology/Oncology and the Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY
⁴Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York

Elena Buces^1,2*, Carolina Martínez-Laperche^1,3*, M Carmen Aguilera^4*, Antoni Picornell^1,3*, Rosa Lillo^4*, Milagros González-Rivera^3,5*, Anna Bosch-Vizcaya^6*, Beatriz Martín-Antonio^7*, Jose B Nieto^8*, Vicent Guillem^9*, Marcos González, MD, PhD^10*, Rafael De la Cámara^11*, Salut Brunet, MD, PhD^12*, Antonio Jimenez-Velasco^13*, Ildefonso Espigado, MD, PhD¹⁴, Carlos Vallejo^15*, Antonia Sampol, MD, PhD^16*, David Serrano^1,3*, Mi Kwon, MD^1,2*, Jorge Gayoso^1,3*, Pascual Balsalobre, PhD^1,3*, Álvaro Urbano-Izpizua^7*, Carlos Solano, M.D.¹⁷, David Gallardo^6*, José Luis Díez Martín^18,19, Juan Romo^4* and Ismael Buno^1,3*

¹Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
²Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
³Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁴Department of Statistics, Universidad Carlos III de Madrid, Madrid, Spain
⁵Instituto de Investigación Sanitaria, Madrid, Spain
⁶ICO Hospital Josep Trueta, Girona, Spain
⁷Hospital Clínic, IDIBAPS, Barcelona, Spain
⁸Hospital Universitario Morales Meseguer, Murcia, Spain
⁹Hospital Clínico de Valencia, Valencia, Spain
¹⁰Hospital Clínico Universitario de Salamanca, Salamanca, Spain
¹¹Hospital Universitario de La Princesa, Madrid, Spain
¹²Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
¹³Hospital Regional de Málaga, Málaga, Spain
¹⁴Hospital Universitario Virgen del Rocío, Sevilla, Sevilla, Spain
¹⁵Hospital central de Asturias, Oviedo, Spain
¹⁶Hospital Son Espases, Palma de Mallorca, Spain
¹⁷Hospital Clinico de Valenci, Valencia, Spain
¹⁸Hematology Service, Hospital Gregorio Marañón. Health Research Institute Gregorio Marañón., Madrid, Spain
¹⁹Instituto de Investigacion Sanitaria Hospital Gregorio Marañon, Madrid, Spain

Frances T. Hakim, PhD^1*, Sarfraz Memon, MD^1*, Ping Jin, PhD^2*, Matin M. Imanguli, DDS, MD^1*, Najibah Rehman, MD^1*, Xiao-Yi Yan, MS^1*, Jeremy J. Rose, BA^1*, Jacqueline W. Mays, DDS, PhD^3*, Susan Dhamala, BA^1*, Veena Kapoor^1*, William Telford, PhD^1*, David C. Halverson, MD^1*, Kristin Baird, MD^4,5*, Daniel H. Fowler, MD^1*, David Stroncek, MD⁶, Edward W. Cowen, MD, MHSc^7*, Steven Z. Pavletic, MD¹ and Ronald E. Gress, MD¹

¹Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Department of Transfusion Medicine, National Institutes of Health, Clinical Center, Bethesda, MD
³Clinical Research Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD
⁴Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Center For Biologics Evaluation and Research, FDA, Rockville, MD
⁶Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD
⁷Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

Takanori Yoshioka, MD^1*, Yusuke Meguri, MD^1*, Takeru Asano, MD^1*, Yuriko Kishi^1*, Miki Iwamoto^1*, Yoshinobu Maeda, MD, PhD¹, Mitsune Tanimoto, MD, PhD¹ and Ken-Ichi Matsuoka, MD, PhD^2*

¹Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
²Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Edouard Forcade, MD^1,2*, Haesook T. Kim, PhD^3,4*, Corey S Cutler, MD, MPH^1,2, Kathy S. Wang, PhD^1,2, Vincent T Ho, MD^2,5, John Koreth, MBBS, DPhil^1,2, Philippe Armand, MD, PhD^1,2, Edwin P. Alyea, MD^2,6, Bruce R. Blazar, MD⁷, Robert J. Soiffer, MD^2,5, Joseph H. Antin, MD^1,2 and Jerome Ritz, MD^2,8

¹Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Harvard Medical School, Boston, MA
³Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
⁴Harvard School of Public Health, Boston
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Division of Pediatrics, Department of Medicine, University of Minnesota Cancer Center, Minneapolis, MN
⁸Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA